|
|
Volumn 29, Issue 36, 2010, Pages 5048-5060
|
|
TRAIL treatment provokes mutations in surviving cells
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CASPASE;
CASPASE 8 INHIBITOR;
CASPASE ACTIVATED DEOXYRIBONUCLEASE;
CISPLATIN;
CYTOKINE RESPONSE MODIFIER A;
DEATH RECEPTOR;
FAS LIGAND;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;
ANTINEOPLASTIC AGENT;
DEOXYRIBONUCLEASE;
SMALL INTERFERING RNA;
ANIMAL CELL;
ARTICLE;
CANCER THERAPY;
CELL SURVIVAL;
CELL VIABILITY;
DNA DAMAGE;
DOWN REGULATION;
MOUSE;
MUTAGENESIS;
MUTATION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
ANIMAL;
BIOLOGICAL MODEL;
CELL CULTURE;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG RESISTANCE;
FIBROBLAST;
GENETICS;
METABOLISM;
NEOPLASM;
PATHOLOGY;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL SURVIVAL;
CELLS, CULTURED;
CISPLATIN;
DEOXYRIBONUCLEASES;
DRUG RESISTANCE, NEOPLASM;
FIBROBLASTS;
MICE;
MODELS, BIOLOGICAL;
MUTATION;
NEOPLASMS;
RNA, SMALL INTERFERING;
TNF-RELATED APOPTOSIS-INDUCING LIGAND;
|
|
EID: 77956630795
PISSN: 09509232
EISSN: 14765594
Source Type: Journal
DOI: 10.1038/onc.2010.242 Document Type: Article |
|
Times cited : (75)
|
|
References (0)
|
